CVS HEALTH CORPORATION (CVS) FY2023 Annual Statement of Cash Flows
2023-01-01 to 2023-12-31
Statement of Cash Flows
2023-01-01 to 2023-12-31
Swipe to see the full flow
Chart details
CVS HEALTH CORPORATION cash flow reconciliation, Jan 1, 2023 through Dec 31, 2023
Cash flows for Jan 1, 2023 through Dec 31, 2023. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2022. Ending cash: Dec 31, 2023. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.
- Beginning cash on Dec 31, 2022
- 13,305,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- Operating activities
- 13,426,000,000 US dollars. Net cash provided.
- Gain on sale of subsidiaries
- 0 US dollars
- Other assets
- negative 510,000,000 US dollars
- Health care costs payable and other insurance liabilities
- 394,000,000 US dollars
- Loss on early extinguishment of debt
- 0 US dollars
- Inventories
- 1,233,000,000 US dollars
- Accounts receivable, net
- negative 6,260,000,000 US dollars
- Deferred income taxes
- negative 676,000,000 US dollars
- Other liabilities
- 1,540,000,000 US dollars
- Net income
- 8,368,000,000 US dollars
- Goodwill impairment
- 0 US dollars
- Store impairments
- 0 US dollars
- Depreciation and amortization
- 4,366,000,000 US dollars
- Other noncash items
- 416,000,000 US dollars
- Stock-based compensation
- 588,000,000 US dollars
- Accounts payable and pharmacy claims and discounts payable
- 3,618,000,000 US dollars
- Loss on assets held for sale
- 349,000,000 US dollars
- Investing activities
- negative 20,889,000,000 US dollars. Net cash used.
- Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,854 in 2022)
- 0 US dollars
- Proceeds from sales and maturities of investments
- 7,729,000,000 US dollars
- Purchases of investments
- negative 9,043,000,000 US dollars
- Purchases of property and equipment
- negative 3,031,000,000 US dollars
- Acquisitions (net of cash and restricted cash acquired)
- negative 16,612,000,000 US dollars
- Other
- 68,000,000 US dollars
- Financing activities
- 2,683,000,000 US dollars. Net cash provided.
- Commercial paper borrowings (repayments), net
- 200,000,000 US dollars
- Proceeds from issuance of short-term loan
- 5,000,000,000 US dollars
- Repayment of short-term loan
- negative 5,000,000,000 US dollars
- Proceeds from issuance of long-term debt
- 10,898,000,000 US dollars
- Repayments of long-term debt
- negative 3,166,000,000 US dollars
- Repurchase of common stock
- negative 2,012,000,000 US dollars
- Dividends paid
- negative 3,132,000,000 US dollars
- Proceeds from exercise of stock options
- 277,000,000 US dollars
- Payments for taxes related to net share settlement of equity awards
- negative 181,000,000 US dollars
- Other
- negative 201,000,000 US dollars
- Operating adjustment reconciliation
- 12,504,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- financing gross reconciliation
- 16,375,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- investing gross reconciliation
- 28,686,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- Exchange-rate effect
- 0 US dollars
- Ending cash on Dec 31, 2023
- 8,525,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- Cash sources and uses
- 29,414,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- Net cash change
- negative 4,780,000,000 US dollars. Ending cash minus beginning cash.
- Cash flow / Net income
- 1.60×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
- Operating cash flow
- 13,426,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
- Cash purchases of property, plant and equipment
- 3,031,000,000 US dollars. These cash purchases are already included in investing activities above.
- Free cash flow
- 10,395,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.
Chart connections
- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $5.06B after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 13,426,000,000 US dollars minus 3,031,000,000 US dollars equals 10,395,000,000 US dollars.
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!